Expected FDA Impact of a Government Shutdown
Critically, the critical public health mission and user fees are [...]
Government Shutdown 101: What to Expect
March 14th is approaching fast, and it increasingly looks like [...]
Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers
Understanding the patient experience with CAR-T long-term follow-up (LTFU) is [...]
Catalyst advances women’s health in new LinkedIn article
On Tuesday, Catalyst's Taryn Serman and Nancy Myers, together with [...]
The Catalyst Team shows support on Rare Disease Day
Being rare is often a blessing: a rare gem stands [...]
Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace.
Scientific innovation in Cell & Gene Therapy (C>) is advancing [...]
The launch of a patient-focused nonprofit: Catalyst Healthcare Consulting lends a hand
Two integral parts of Catalyst’s corporate mission are to 1) [...]
FDA Office of the Ombudsman: Focusing on Communication and Ensuring All Voices Are Heard
During an interview with the Alliance for a Stronger FDA [...]
Califf: FDA will be a ‘more activist’ agency
Regulatory Focus - Aug. 24, 2023 Note: This article describes an [...]
Telework helps FDA compete for scientists. What if it’s no longer an option?
STAT+ May 11, 2023 Catalyst CEO and Founder Nancy Bradish [...]